glipizide tablet extended release
1 INDICATIONS AND USAGE Glipizide extended-release tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Glipizide extended-release tablets is a sulfonylurea indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Limitations of Use: Not for treatment of type 1 diabetes or diabetic ketoacidosis. 1.1 Limitations of Use Glipizide extended-release tablets are not recommended for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis.
american health packaging
Related Pills
glipizide 10 mg extended release
american health packaging
glipizide 2.5 mg extended release
american health packaging
mirtazapine 7.5 mg
AvKARE
pepto bismol fast melts winter frost flavored bismuth subsalicylate tablet chewable
the procter & gamble manufacturing company
pepto bismol fast melts fresh berry flavored bismuth subsalicylate tablet chewable
the procter & gamble manufacturing company
coldeeze cold remedy ultramelt chews zinc gluconate tablet chewable
vespyr brands inc
Chantix First Month of Therapy Pack
Physicians Total Care, Inc.
Norco 10325 hydrocodone APAP Oral Tablet
Watson Pharma, Inc.
KlorCon 20 MEQ Extended Release Tablet
McKesson Contract Packaging
Guaifenesin 400 MG Oral Tablet
Sunrise Pharmaceutical Inc
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING
GLIPIZIDE Extended-Release Tablets, 2.5 mg are white to off-white, round, biconvex film-coated tablets imprinted with ‘A’ on one side with black ink. Unit dose packages of 30 (3 x 10) NDC 60687-480-21 Recommended Storage: The tablets should be protected from moisture and humidity. Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. FOR YOUR PROTECTION: Do not use if blister is torn or broken.
More pills like ROUND C